Literature DB >> 1344978

Diagnostic outcome in children with multiple café au lait spots.

B R Korf1.   

Abstract

Forty-one children, ranging in age from 1 month to 14 years, had six or more café au lait spots at their initial visit and were examined annually. Signs of neurofibromatosis type 1 eventually developed in 24. The most common feature to appear to confirm the diagnosis was skin-fold freckling, which occurred in 18 subjects. Diagnosis was based on the appearance of Lisch nodules in 5, and on neurofibromas in 3. In most instances, diagnosis was established within 3 years of initial evaluation, usually before 5 years of age. Six children had a segmental distribution of café au lait spots, suggesting segmental neurofibromatosis. In 3, diagnoses other than neurofibromatosis type 1 were established (Bannayan-Riley-Rulvalcaba syndrome, multiple lentigines syndrome, and fibrous dysplasia). In 8 subjects only multiple café au lait spots are present, and no definite diagnosis has been established. It is concluded that with regular follow-up, including physical and ophthalmological examinations, a definite diagnosis, most commonly neurofibromatosis type 1, can be established for most children having multiple café au lait spots.

Entities:  

Mesh:

Year:  1992        PMID: 1344978

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  A novel NF1 gene mutation in an Italian family with neurofibromatosis type 1.

Authors:  Anna Lia Gabriele; Martino Ruggieri; Alessandra Patitucci; Angela Magariello; Francesca Luisa Conforti; Rosalucia Mazzei; Maria Muglia; Carmine Ungaro; Gemma Di Palma; Luigi Citrigno; William Sproviero; Antonio Gambardella; Aldo Quattrone
Journal:  Childs Nerv Syst       Date:  2010-10-07       Impact factor: 1.475

2.  The value of screening tests in children with neurofibromatosis type 1 (NF1).

Authors:  Eloïse Baudou; Yves Chaix
Journal:  Childs Nerv Syst       Date:  2020-06-10       Impact factor: 1.475

3.  LEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria.

Authors:  Atilano Carcavilla; Isabel Pinto; Rafael Muñoz-Pacheco; Raquel Barrio; Maria Martin-Frías; Begoña Ezquieta
Journal:  Eur J Pediatr       Date:  2011-03-02       Impact factor: 3.183

4.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

5.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

Review 6.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

Authors:  Katharina Wimmer; Julia Etzler
Journal:  Hum Genet       Date:  2008-08-18       Impact factor: 4.132

7.  Von Recklinghausen's Disease Presenting as Otolaryngologic Emergency: A Rare Occurrence.

Authors:  Debangshu Ghosh; Jayanta Saha; Shaswati Sengupta; Ajay Manickam; Sumit Kumar Basu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-24

8.  Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?

Authors:  J D Trimbath; G M Petersen; S H Erdman; M Ferre; M C Luce; F M Giardiello
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

9.  Intercostal aneurysm causing spinal cord compression in an NF1 patient.

Authors:  Varun Puvanesarajah; Ioan A Lina; Jason A Liauw; Alex L Coon; Timothy F Witham
Journal:  Eur Spine J       Date:  2013-04-19       Impact factor: 3.134

10.  Primary osteoma cutis--multiple café-au-lait spots and woolly hair anomaly.

Authors:  M Ruggieri; V Pavone; P Smilari; R Rizzo; G Sorge
Journal:  Pediatr Radiol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.